To predict the next move in Boston Scientific (BSX) stock following their $2 billion Accelerated Share Repurchase (ASR) with JPMorgan Chase, monitor the final settlement before June 30, 2026, and track the stock's volume-weighted average price (VWAP).
Track BSX's performance using the Yahoo Finance BSX Chart.
Key metrics to help predict the stock's next movements include:
- Final VWAP Pricing: The final number of shares Boston Scientific receives will be determined by the stock's VWAP over the ASR period. If the stock dips during this timeframe, JPMorgan Chase will need to deliver more shares, causing a more substantial drop in the total outstanding float and benefiting long-term earnings per share (EPS).
- Initial Delivery & EPS Growth: BSX initially received roughly 30.4 million shares (80% of the repurchase price) based on the May 15, 2026, closing price of . This move is immediately accretive and is expected to add aboutto BSX's 2026 adjusted EPS.
- The "Short Squeeze" Effect: During an ASR, the acting investment bank (JPMorgan) usually borrows shares to deliver to the company, meaning the bank must then go into the open market over the duration of the agreement to buy those shares back and close its position. This built-in purchasing pressure generally acts as a stabilizing floor or upward catalyst for the stock price.
- Remaining Authorization: Upon completion of this ASR, BSX will still have billion remaining in its authorized buyback program, leaving the door open for future repurchase agreements.
Note: In addition to the buyback, BSX announced a
billion equity investment in MiRus LLC, which analysts at firms like Truist Securities believe provides a strong growth trajectory with price targets generally set around
.
No comments:
Post a Comment